Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

Wermke M, Ochsenreither S, Jaeger D, Becker H, Bleckmann A, Bozorgmehr F, Chatterjee M, Groepper S, Haenel M, Hecker JS, Häring MF, Heudobler D, Hilf N, Hofmann M, Hutt M, Mayer-Mokler A, Missel S, Ruh M, Schuster H, Veremchuk O, Kleemiss M, Knop S, Laban S, Sebastian M, Spoerl S, Britten CM, Reinhardt C.

Open source

DOI: 10.1038/s41591-026-04519-y
Published: 2026-08-01
Container: Nat Med
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04519-y,
  title = {Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.},
  author = {Wermke M and  Ochsenreither S and  Jaeger D and  Becker H and  Bleckmann A and  Bozorgmehr F and  Chatterjee M and  Groepper S and  Haenel M and  Hecker JS and  Häring MF and  Heudobler D and  Hilf N and  Hofmann M and  Hutt M and  Mayer-Mokler A and  Missel S and  Ruh M and  Schuster H and  Veremchuk O and  Kleemiss M and  Knop S and  Laban S and  Sebastian M and  Spoerl S and  Britten CM and  Reinhardt C.},
  year = {2026},
  journal = {Nat Med},
  doi = {10.1038/s41591-026-04519-y},
  url = {https://doi.org/10.1038/s41591-026-04519-y}
}

RIS

TY  - JOUR
TI  - Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.
AU  - Wermke M
AU  -  Ochsenreither S
AU  -  Jaeger D
AU  -  Becker H
AU  -  Bleckmann A
AU  -  Bozorgmehr F
AU  -  Chatterjee M
AU  -  Groepper S
AU  -  Haenel M
AU  -  Hecker JS
AU  -  Häring MF
AU  -  Heudobler D
AU  -  Hilf N
AU  -  Hofmann M
AU  -  Hutt M
AU  -  Mayer-Mokler A
AU  -  Missel S
AU  -  Ruh M
AU  -  Schuster H
AU  -  Veremchuk O
AU  -  Kleemiss M
AU  -  Knop S
AU  -  Laban S
AU  -  Sebastian M
AU  -  Spoerl S
AU  -  Britten CM
AU  -  Reinhardt C.
PY  - 2026
JO  - Nat Med
DO  - 10.1038/s41591-026-04519-y
UR  - https://doi.org/10.1038/s41591-026-04519-y
ER  -

APA

M, W., S, O., D, J., H, B., A, B., F, B., M, C., S, G., M, H., JS, H., MF, H., D, H., N, H., M, H., M, H., A, M., S, M., M, R., H, S., O, V., M, K., S, K., S, L., M, S., S, S., CM, B., & C., R. (2026). Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.. Nat Med. https://doi.org/10.1038/s41591-026-04519-y

Source records

europe-pmc · retrieved 2026-09-25T23:12:00.215Z